This website uses cookies to ensure proper functionality of the shopping cart and checkout progress. By continuing to browse the site you are agreeing to the use of cookies. Click here to learn about cookie settings.
Peptide-based inhibitor of protein kinase G type Iα and Iβ. Detailed technical information available. Reference: Dostmann et al., Proc. Natl. Acad. Sci. USA, 97, 14772 - 14777 (2000). Biolog also offers the control peptide W45 (Cat. No. W 001).
2. Lohmann S. M.Walter U., Frontiers Biosci., 10, 1313 - 1328 (2005), "Tracking Functions of cGMP-dependent Protein Kinase"
3. Dostmann W. R. G., Tegge W., Frank R., Nickl C. K., Taylor M. S.Brayden J. E., Pharmacol. Ther., 93, 203 - 215 (2002), "Exploring the Mechanisms of Vascular Smooth Muscle Tone with Highly Specific, Membrane-permeable Inhibitors of Cyclic GMP-dependent Protein Kinase I Alpha"
4. Dostmann W. R. G., Nickl C. K., Taylor M. S., Brayden J. E., Frank R.Ten Eyck L. F., Cell. Biol. Mol. Lett., 6, 458 - 458 (2001), "Highly Specific and Membrane Permeant Peptide Inhibitors of cGMP-Dependent Protein Kinase I alpha"
5. Dostmann W. R. G., Taylor M. S., Nickl C. K., Brayden J. E., Frank R.Tegge W., Proc. Natl. Acad. Sci. U.S.A., 97, 14772 - 14777 (2000), "Highly Specific, Membrane-permeant Peptide Blockers of cGMP-dependent Protein Kinase I Alpha Inhibit NO-induced Cerebral Dilation"